Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Embecta Corp. stock logo
EMBC
Embecta
$10.88
$12.97
$9.93
$32.00
$626.47M0.73409,523 shs148,019 shs
NuVasive, Inc. stock logo
NUVA
NuVasive
$39.75
$39.64
$35.17
$49.53
$2.08B1.071.16 million shsN/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$52.85
-1.7%
$49.19
$24.83
$54.79
$2.69B1.01497,509 shs416,727 shs
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$17.54
-0.7%
$17.50
$6.08
$45.41
$687.04M1.48792,027 shs380,067 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Embecta Corp. stock logo
EMBC
Embecta
+1.49%+5.12%-12.33%-35.51%-62.18%
NuVasive, Inc. stock logo
NUVA
NuVasive
0.00%0.00%0.00%0.00%-7.73%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
+5.00%+3.39%+12.75%+18.55%+51.62%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
+1.49%-0.23%-5.10%+18.19%-61.07%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Embecta Corp. stock logo
EMBC
Embecta
3.1878 of 5 stars
2.81.03.30.01.93.31.9
NuVasive, Inc. stock logo
NUVA
NuVasive
1.9648 of 5 stars
3.30.00.00.00.00.03.1
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
0.5307 of 5 stars
1.51.00.00.02.43.30.6
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
3.1947 of 5 stars
3.11.00.04.31.31.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Embecta Corp. stock logo
EMBC
Embecta
1.50
Reduce$16.0047.06% Upside
NuVasive, Inc. stock logo
NUVA
NuVasive
2.50
Moderate Buy$51.3329.14% Upside
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
3.00
Buy$45.60-13.72% Downside
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
2.18
Hold$22.1826.46% Upside

Current Analyst Ratings

Latest SILK, NUVA, PRCT, and EMBC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/7/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$24.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $23.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$10.00 ➝ $19.00
2/29/2024
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$11.00 ➝ $18.00
2/28/2024
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$55.00 ➝ $58.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Embecta Corp. stock logo
EMBC
Embecta
$1.12B0.56$3.75 per share2.90($14.34) per share-0.76
NuVasive, Inc. stock logo
NUVA
NuVasive
$1.23B1.70$4.96 per share8.01$17.02 per share2.34
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$136.19M19.78N/AN/A$5.56 per share9.51
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$177.13M3.88N/AN/A$3.88 per share4.52

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Embecta Corp. stock logo
EMBC
Embecta
$70.40M$0.9511.454.92N/A4.93%-18.66%12.38%5/9/2024 (Confirmed)
NuVasive, Inc. stock logo
NUVA
NuVasive
$40.41M$0.5079.5015.35N/A2.32%12.17%4.88%N/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$105.90M-$2.24N/AN/AN/A-77.75%-46.59%-30.63%5/1/2024 (Confirmed)
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$55.74M-$1.44N/AN/AN/A-31.70%-36.38%-21.41%4/30/2024 (Confirmed)

Latest SILK, NUVA, PRCT, and EMBC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Embecta Corp. stock logo
EMBC
Embecta
$0.43N/A-$0.43N/AN/AN/A
5/1/2024N/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.55N/A+$0.55N/AN/AN/A  
4/30/2024N/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40N/A+$0.40N/AN/AN/A  
2/28/2024Q4 2023
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$0.40-$0.33+$0.07-$0.33$42.23 million$47.27 million    
2/27/2024Q4 2023
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.44-$0.54-$0.10-$0.54$41.79 million$43.58 million      
2/9/202412/31/2023
Embecta Corp. stock logo
EMBC
Embecta
$0.46$0.61+$0.15$0.85$264.92 million$277.30 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Embecta Corp. stock logo
EMBC
Embecta
$0.605.51%N/A63.16%N/A
NuVasive, Inc. stock logo
NUVA
NuVasive
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/AN/AN/AN/AN/A

Latest SILK, NUVA, PRCT, and EMBC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/9/2024
Embecta Corp. stock logo
EMBC
Embecta
Quarterly$0.153.69%2/27/20242/28/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.20
1.75
NuVasive, Inc. stock logo
NUVA
NuVasive
0.50
1.25
0.65
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
0.18
7.63
6.77
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.50
7.95
6.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Embecta Corp. stock logo
EMBC
Embecta
93.83%
NuVasive, Inc. stock logo
NUVA
NuVasive
N/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
89.46%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/A

Insider Ownership

CompanyInsider Ownership
Embecta Corp. stock logo
EMBC
Embecta
0.28%
NuVasive, Inc. stock logo
NUVA
NuVasive
0.53%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
19.60%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
6.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Embecta Corp. stock logo
EMBC
Embecta
2,20057.58 million57.42 millionOptionable
NuVasive, Inc. stock logo
NUVA
NuVasive
3,00052.45 million52.17 millionOptionable
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
62650.96 million40.98 millionOptionable
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
47439.17 million36.55 millionOptionable

SILK, NUVA, PRCT, and EMBC Headlines

SourceHeadline
Silk Road Medical to Present at the BofA Securities 2024 Healthcare ConferenceSilk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
globenewswire.com - April 23 at 4:30 PM
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to BuyAll You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
zacks.com - April 23 at 1:00 PM
Silk Road Medical (SILK) to Release Quarterly Earnings on TuesdaySilk Road Medical (SILK) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - April 23 at 4:32 AM
Silk Road Medical (SILK) to Release Earnings on TuesdaySilk Road Medical (SILK) to Release Earnings on Tuesday
marketbeat.com - April 23 at 4:30 AM
The Silk Road of the SeaThe Silk Road of the Sea
sundaytimes.lk - April 22 at 3:28 PM
Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.Heard of Zoroastrianism in history class? The ancient religion still has fervent followers.
nationalgeographic.com - April 22 at 3:28 PM
Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)Peregrine Capital Management LLC Sells 338,639 Shares of Silk Road Medical, Inc (NASDAQ:SILK)
marketbeat.com - April 12 at 6:44 AM
Silk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from BrokeragesSilk Road Medical, Inc (NASDAQ:SILK) Receives Consensus Rating of "Hold" from Brokerages
marketbeat.com - April 12 at 2:17 AM
Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%Silk Road Medical (NASDAQ:SILK) Stock Price Up 3.5%
marketbeat.com - April 11 at 12:45 PM
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
globenewswire.com - April 9 at 4:30 PM
Silk Road Medicals (SILK) New Launch to Aid Its TCAR PortfolioSilk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
zacks.com - April 8 at 11:25 AM
China, Sri Lanka forging stronger bondsChina, Sri Lanka forging stronger bonds
chinadaily.com.cn - April 7 at 3:48 PM
Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%Silk Road Medical (NASDAQ:SILK) Trading Up 5.1%
marketbeat.com - April 5 at 3:45 PM
Taiwan Earthquake: What to Know About Travel and How to HelpTaiwan Earthquake: What to Know About Travel and How to Help
msn.com - April 5 at 1:08 AM
The One and Only Benedict WongThe One and Only Benedict Wong
vulture.com - April 4 at 7:57 AM
Silk Road Medical Launches Enroute Transcarotid NPS PlusSilk Road Medical Launches Enroute Transcarotid NPS Plus
evtoday.com - April 4 at 7:57 AM
Worker injured by electric shock from power line in BiddefordWorker injured by electric shock from power line in Biddeford
finance.yahoo.com - April 3 at 11:54 AM
Silk Road launches next-gen transcarotid neuroprotection systemSilk Road launches next-gen transcarotid neuroprotection system
massdevice.com - April 3 at 11:54 AM
Ancient People Also Had Sunburns, So They Used These 4 Forms of ProtectionAncient People Also Had Sunburns, So They Used These 4 Forms of Protection
msn.com - April 3 at 6:53 AM
Traditional Chinese medicine gains wider recognition around worldTraditional Chinese medicine gains wider recognition around world
sb.by - April 3 at 6:53 AM
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUSSilk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
globenewswire.com - April 2 at 4:30 PM
Turkmenistan to launch traffic on Tejen - Mary expresswayTurkmenistan to launch traffic on Tejen - Mary expressway
en.trend.az - March 30 at 2:13 PM
Number of Russian Crocus City Hall terrorist attack victims increasesNumber of Russian Crocus City Hall terrorist attack victims increases
en.trend.az - March 30 at 2:13 PM
Rep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need A Global PerspectiveRep. Barbara Lee Doubles Down On Opposing Military Budget: Black People Need 'A Global Perspective'
theroot.com - March 29 at 2:31 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Embecta logo

Embecta

NASDAQ:EMBC
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
NuVasive logo

NuVasive

NASDAQ:NUVA
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California. As of September 1, 2023, NuVasive, Inc. operates as a subsidiary of Globus Medical, Inc.
PROCEPT BioRobotics logo

PROCEPT BioRobotics

NASDAQ:PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Silk Road Medical logo

Silk Road Medical

NASDAQ:SILK
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.